Advances in the Relationship between Osteosarcopenic Obesity Syndrome and Type 2 Diabetes
Department of Geriatrics,the First Affiliated Hospital of Chongqing Medical University,400016 Chongqing,China
*Corresponding author:ZHAO Kexiang,Associate chief physician;E-mail:1287405922@qq.com
WAN Jiamin,ZHAO Kexiang,SUN Yue, et al. Advances in the Relationship between Osteosarcopenic Obesity Syndrome and Type 2 Diabetes [J]. Chinese General Practice, 2021, 24(9): 1152-1157. DOI: 10.12114/j.issn.1007-9572.2021.00.062.
万家敏,赵柯湘,孙悦等. 骨量-肌量减少性肥胖综合征与2型糖尿病关系的研究进展[J]. 中国全科医学, 2021, 24(9): 1152-1157. DOI: 10.12114/j.issn.1007-9572.2021.00.062.
[1]ORMSBEE M J,PRADO C M,ILICH J Z,et al.Osteosarcopenic obesity:the role of bone,muscle,and fat on health[J].J Cachexia Sarcopenia Muscle,2014,5(3):183-192.DOI:10.1007/s13539-014-0146-x.
[2]ZAMBONI M,MAZZALI G,FANTIN F,et al.Sarcopenic obesity:a new category of obesity in the elderly[J].Nutr Metab Cardiovasc Dis,2008,18(5):388-395.DOI:10.1016/j.numecd.2007.10.002.
[3]ILICH J Z,KELLY O J,INGLIS J E,et al.Interrelationship among muscle,fat,and bone:connecting the dots on cellular,hormonal,and whole body levels[J].Ageing Res Rev,2014,15:51-60.DOI:10.1016/j.arr.2014.02.007.
[4]KIM J,LEE Y,KYE S,et al.Association of serum vitamin D with osteosarcopenic obesity:Korea National Health and Nutrition Examination Survey 2008—2010[J].J Cachexia Sarcopenia Muscle,2017,8(2):259-266.DOI:10.1002/jcsm.12154.
[5]SZLEJF C,PARRA-RODRíGUEZ L,ROSAS-CARRASCO O.Osteosarcopenic obesity:prevalence and relation with frailty and physical performance in middle-aged and older women[J].J Am Med Dir Assoc,2017,18(8):733.e1-5.DOI:10.1016/j.jamda.2017.02.023.
[6]ILICH J Z,INGLIS J E,KELLY O J,et al.Osteosarcopenic obesity is associated with reduced handgrip strength,walking abilities,and balance in postmenopausal women[J].Osteoporos Int,2015,26(11):2587-2595.DOI:10.1007/s00198-015-3186-y.
[7]MO D,HSIEH P,YU H,et al.Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China[J].Arch Osteoporos,2018,13(1):65.DOI:10.1007/s11657-018-0481-1.
[8]WOO T,YU S,VISVANATHAN R.Systematic literature review on the relationship between biomarkers of sarcopenia and quality of life in older people[J].J Frailty Aging,2016,5(2):88-99.DOI:10.14283/jfa.2016.93.
[9]STEFANAKI C,PEPPA M,BOSCHIERO D,et al.Healthy overweight/obese youth:early osteosarcopenic obesity features[J].Eur J Clin Invest,2016,46(9):767-778.DOI:10.1111/eci.12659.
[10]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.DOI:10.3969/j.issn.1674-2591.2017.05.002.
[11]于宝海,吴文娟.2018年欧洲肌少症共识解读[J].河北医科大学学报,2019,40(4):373-379,384.DOI:10.3969/j.issn.1007-3205.2019.04.001.
[12]OLIVEROS E,SOMERS V K,SOCHOR O,et al.The concept of normal weight obesity[J].Prog Cardiovasc Dis,2014,56(4):426-433.DOI:10.1016/j.pcad.2013.10.003.
[13]HUNG S P,CHEN C Y,GUO F R,et al.Combine body mass index and body fat percentage measures to improve the accuracy of obesity screening in young adults[J].Obes Res Clin Pract,2017,11(1):11-18.DOI:10.1016/j.orcp.2016.02.005.
[14]LI Z P,HEBER D.Sarcopenic obesity in the elderly and strategies for weight management[J].Nutr Rev,2012,70(1):57-64.DOI:10.1111/j.1753-4887.2011.00453.x.
[15]HUANG Y,KARURANGA S,MALANDA B,et al.Call for data contribution to the IDF Diabetes Atlas 9th Edition 2019[J].Diabetes Res Clin Pract,2018,140:351-352.DOI:10.1016/j.diabres.2018.05.033.
[16]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.DOI:10.19538/j.nk2018040108.
Chinese Diabetes Societys.Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)[J].Chinese Journal of Practical Internal Medicine,2018,38(4):292-344.DOI:10.19538/j.nk2018040108.
[17]FRIEDLAENDER G E.The role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fractures[J].J Am Acad Orthop Surg,2010,18(9):515.DOI:10.5435/00124635-201009000-00001.
[18]KOH W P,WANG R,ANG L W,et al.Diabetes and risk of hip fracture in the Singapore Chinese health study[J].Diabetes Care,2010,33(8):1766-1770.DOI:10.2337/dc10-0067.
[19]STYNER M,PAGNOTTI G M,GALIOR K,et al.Exercise regulation of marrow fat in the setting of PPARγ agonist treatment in female C57BL/6 mice[J].Endocrinology,2015,156(8):2753-2761.DOI:10.1210/en.2015-1213.
[20]MARYCZ K,TOMASZEWSKI K A,KORNICKA K,et al.Metformin decreases reactive oxygen species,enhances osteogenic properties of adipose-derived multipotent mesenchymal stem cells in vitro,and increases bone density in vivo[J].Oxidative Med Cell Longev,2016,2016:9785890.DOI:10.1155/2016/9785890.
[21]刘冬梅,刘建民,陈名道.骨骼对维持血糖稳态的作用[J].中华内分泌代谢杂志,2016,12:1015-1022.DOI:10.3760/cma.j.issn.1000-6699.2016.12.008.
LIU D M,LIU J M,CHEN M D.The regulatory role of skeleton in maintaining glucose homeostasis[J].Chinese Journal of Endocrinology and Metabolism,2016,32(12):1015-1022.DOI:10.3760/cma.j.issn.1000-6699.2016.12.008.
[22]ZHOU B.Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J].Chin J Epidemiol,2002,23(1):5.
[23]BUETTNER C.Is hyperinsulinemia required to develop overeating-induced obesity?[J].Cell Metab,2012,16(6):691-692.DOI:10.1016/j.cmet.2012.11.009.
[24]范利.老年肌少症与衰弱综合征之间的关系[J].中华保健医学杂志,2014,16(6):415-416.DOI:10.3969/.issn.1674-3245.2014.06.001.
[25]KIM K S,PARK K S,KIM M J,et al.Type 2 diabetes is associated with low muscle mass in older adults[J].Geriatr Gerontol Int,2014,14:115-121.DOI:10.1111/ggi.12189.
[26]SEMBA R D,BANDINELLI S,SUN K,et al.Relationship of an advanced glycation end product,plasma carboxymethyl-lysine,with slow walking speed in older adults:the InCHIANTI study[J].Eur J Appl Physiol,2010,108(1):191-195.DOI:10.1007/s00421-009-1192-5.
[27]YAU R K,STROTMEYER E S,RESNICK H E,et al.Diabetes and risk of hospitalized fall injury among older adults[J].Diabetes Care,2013,36(12):3985-3991.DOI:10.2337/dc13-0429.
[28]TUTTLE L J,SINACORE D R,CADE W T,et al.Lower physical activity is associated with higher intermuscular adipose tissue in people with type 2 diabetes and peripheral neuropathy[J].Phys Ther,2011,91(6):923-930.DOI:10.2522/ptj.20100329.
[29]AGHILI R,MALEK M,VALOJERDI A E,et al.Body composition in adults with newly diagnosed type 2 diabetes:effects of metformin[J].J Diabetes Metab Disord,2014,13:88.DOI:10.1186/s40200-014-0088-z.
[30]CETRONE M,MELE A,TRICARICO D.Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes typeⅡ[J].Curr Diabetes Rev,2014,10(4):231-237.DOI:10.2174/1573399810666140918121022.
[31]MRAZ M,HALUZIK M.The role of adipose tissue immune cells in obesity and low-grade inflammation[J].J Endocrinol,2014,222(3):R113-127.DOI:10.1530/joe-14-0283.
[32]KIM T N,PARK M S,LIM K I,et al.Relationships between sarcopenic obesity and insulin resistance,inflammation,and vitamin D status:the Korean Sarcopenic Obesity Study[J].Clin Endocrinol (Oxf),2013,78(4):525-532.DOI:10.1111/j.1365-2265.2012.04433.x.
[33]KHADRA D,ITANI L,TANNIR H,et al.Association between sarcopenic obesity and higher risk of type 2 diabetes in adults:a systematic review and meta-analysis[J].World J Diabetes,2019,10(5):311-323.DOI:10.4239/wjd.v10.i5.311.
[34]BINKLEY N,BUEHRING B.Beyond FRAX:it's time to consider “sarco-osteopenia”[J].J Clin Densitom,2009,12(4):413-416.DOI:10.1016/j.jocd.2009.06.004.
[35]TAGLIAFERRI C,WITTRANT Y,DAVICCO M J,et al.Muscle and bone,two interconnected tissues[J].Ageing Res Rev,2015,21:55-70.DOI:10.1016/j.arr.2015.03.002.
[36]TERRACCIANO C,CELI M,LECCE D,et al.Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis[J].Osteoporos Int,2013,24(3):1095-1100.DOI:10.1007/s00198-012-1990-1.
[37]LABONTE C C,CHEVALIER S,MARLISS E B,et al.Effect of 10% dietary protein intake on whole body protein kinetics in type 2 diabetic adults[J].Clin Nutr,2015,34(6):1115-1121.DOI:10.1016/j.clnu.2014.12.022.
[38]陈恒亭,马剑雄,卢斌,等.骨量-肌量减少性肥胖综合征与骨折关系的研究进展[J].中华老年医学杂志,2018,37(3):347-350.DOI:10.3760/cma.j.issn.0254-9026.2018.03.026.
CHEN H T,MA J X,LU B,et al.Research progress on the relationship between osteosarcopenic obesity syndrome and fracture[J].Chinese Journal of Geriatrics,2018,37(3):347-350.DOI:10.3760/cma.j.issn.0254-9026.2018.03.026.
[39]陈兴才,孔存青,徐林,等.骨质疏松性少肌性肥胖综合征的诊断、治疗及相关影响因素[J].中国组织工程研究,2020,24(11):1777-1782.DOI:10.3969/j.issn.2095-4344.2432.
CHEN X C,KONG C Q,XU L,et al.Osteosarcopenic obesity syndrome:diagnosis,treatment and related influencing factors[J].Chinese Journal of Tissue Engineering Research,2020,24(11):1777-1782.DOI:10.3969/j.issn.2095-4344.2432.
[40]KIM J,LEE Y,KYE S,et al.Diet quality and osteosarcopenic obesity in community-dwelling adults 50 years and older[J].Maturitas,2017,104:73-79.DOI:10.1016/j.maturitas.2017.08.007.
[41]TANAKA K I,KANAZAWA I,YAMAGUCHI T,et al.Active vitamin D possesses beneficial effects on the interaction between muscle and bone[J].Biochem Biophys Res Commun,2014,450(1):482-487.DOI:10.1016/j.bbrc.2014.05.145.
[42]ESPOSITO K,CHIODINI P,MAIORINO M I,et al.Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies[J].Endocrine,2014,47(1):107-116.DOI:10.1007/s12020-014-0264-4.